FDNA Expands Facial Analysis Reach to 2,000 Syndromes: New milestone in the fight against rare diseases enables earlier detection and treatment

April 5, 2017

BUSINESS WIRE – “FDNA, a Boston-based digital health company and developer of the Face2Gene suite of applications, is pleased to announce that its facial analysis technology has analyzed facial images of tens of thousands of patients for more than 2,000 different rare genetic diseases. This data is used to recognize associations between facial characteristics and these genetic diseases. This milestone marks a major achievement for a company devoted to ending the lengthy diagnostic journey that accompanies rare diseases.”

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading